SYDNEY, Sept. 05, 2022 (GLOBE NEWSWIRE) -- Ideal for creating areas of shade in a garden or a designated outdoor entertaining zone, pergolas offer a stylish and permanent solution that can be added to the back or side of a property or can stand alone to …
South Korea, Seoul, Sept. 05, 2022 (GLOBE NEWSWIRE) -- According to Fact.MR, a market research and competitive intelligence provider, the global electrical stimulation devices market is expected to reach a valuation of US$ 11 billion by 2027, expanding at …
OTTAWA, ON, Sept. 4, 2022 /CNW/ - Note: All times local The Laurentians, Quebec Personal Vancouver, British Columbia Private meetings This document is also available at https://pm.gc.ca SOURCE Prime Minister's Office View original content: http://www. …
Wugen, Inc., a clinical-stage biotechnology company developing a pipeline of allogeneic cell therapies to treat a broad range of hematological and solid tumor malignancies, today announced it will present preclinical data on WU-NK-101, the company's …
Selected recommended phase 2 dose (RP2D) of 480 mg with ongoing enrollment in disease-specific cohorts; maximum tolerated dose (MTD) not reached Stable disease was observed in 10 of 27 evaluable patients in an unselected patient population Comprehensive …
-- Progression-Free Survival Efficacy of Trodelvy Consistent with That Observed in the TROPiCS-02 Intention-to-Treat Population -- -- Results Presented at ESMO 2022 Highlight Trodelvy as a Potential Treatment Option in HR+/HER2-Low and IHC0 Status …
Zanidatamab zovodotin shown to have manageable safety profile with encouraging, single-agent anti-tumor activity in patients with HER2+ cancers Results to be reviewed in an oral presentation at European Society for Medical Oncology (ESMO) Congress 2022 in …
Median Progression-Free Survival of 11.3 months in first-line gastric cancer patients treated with DKN-01 plus tislelizumab and CAPOX, exceeding benchmarks in the overall population and in DKK1 and PD-L1 subgroups Median Overall Survival is not mature with …
First-in-class Phase 1 data for two investigational bispecifics in advanced ovarian cancer and advanced MET-altered non-small cell lung cancer (NSCLC) to be presented Additional presentations include new data for investigational Libtayo monotherapy and …
INDIANAPOLIS, Sept. 04, 2022 (GLOBE NEWSWIRE) -- POINT Biopharma Global Inc. PNT (the "Company" or "POINT"), a company accelerating the discovery, development, and global access to life-changing radiopharmaceuticals, today announced …
Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until October 31, 2022 to file lead plaintiff applications in a securities class action lawsuit …
85 young leaders have been recognised by the Dutch Ministry of Foreign Affairs and One Young World because of their work in creating prosperity and peace in some of the world's most challenging environments These delegates will attend the upcoming One …
The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Kohl's Corporation ("Kohl's" or "the Company") KSS for violations of §§10(b) and 20(a) of the Securities …
50 young leaders have been recognised by the European Commission and One Young World for their efforts to prevent and counter violent extremism in some of the most challenging environments across the world These delegates will participate in the upcoming …
50 young leaders have been recognised by the European Commission and One Young World for their efforts to prevent and counter violent extremism in some of the most challenging environments across the world These delegates will participate in the upcoming …
NEW YORK, NY / ACCESSWIRE / September 4, 2022 / WHY: New York, N.Y., September 4, 2022. Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Ampio Pharmaceuticals, Inc. AMPE between December 29, 2020 and August 3, 2022 …
SAN DIEGO, CA / ACCESSWIRE / September 4, 2022 / The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of 17 Education & Technology Group Inc. YQ publicly traded securities pursuant and/or traceable to the …
Oral presentation in "Investigational Immunotherapy" session on Saturday, September 10 at 2:45 PM CEST CatalYm today announced that the mature results from its Phase 1, first-in-human trial "GDFATHER-1" (GDF-15 antibody-mediated human …
DUBAI, United Arab Emirates, Sept. 04, 2022 (GLOBE NEWSWIRE) -- Global cowboy boots market is set to witness an impressive growth rate of 6.9% over the forecasted years of 2022 to 2032. The cowboy boots market size is anticipated to reach a valuation of …
03 days 20:03:29
